These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25856682)

  • 1. High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time Trial Performance.
    Koch S; Ahn JR; Koehle MS
    Med Sci Sports Exerc; 2015 Nov; 47(11):2373-9. PubMed ID: 25856682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled salbutamol does not affect athletic performance in asthmatic and non-asthmatic cyclists.
    Koch S; MacInnis MJ; Sporer BC; Rupert JL; Koehle MS
    Br J Sports Med; 2015 Jan; 49(1):51-5. PubMed ID: 24100289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled bronchodilators on lung function and cycling performance in female athletes with and without exercise-induced bronchoconstriction.
    Koch S; Karacabeyli D; Galts C; MacInnis MJ; Sporer BC; Koehle MS
    J Sci Med Sport; 2015 Sep; 18(5):607-12. PubMed ID: 25156879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic Effects of Inhaled Salbutamol on 10-km Time Trial Performance in Competitive Male and Female Cyclists.
    Koch S; MacInnis MJ; Rupert JL; Sporer BC; Koehle MS
    Clin J Sport Med; 2016 Mar; 26(2):145-51. PubMed ID: 25894531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.
    van Baak MA; de Hon OM; Hartgens F; Kuipers H
    Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
    Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported Symptoms after Induced and Inhibited Bronchoconstriction in Athletes.
    Simpson AJ; Romer LM; Kippelen P
    Med Sci Sports Exerc; 2015 Oct; 47(10):2005-13. PubMed ID: 25710876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
    Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salbutamol tolerance to bronchoprotection: course of onset.
    Stewart SL; Martin AL; Davis BE; Cockcroft DW
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
    Dodd JD; Barry SC; Daly LE; Gallagher CG
    J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response of inhaled salbutamol on exercise performance and urine concentrations.
    Sporer BC; Sheel AW; McKenzie DC
    Med Sci Sports Exerc; 2008 Jan; 40(1):149-57. PubMed ID: 18091010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of terbutaline on hyperpnoea-induced bronchoconstriction and urinary club cell protein 16 in athletes.
    Simpson AJ; Tufvesson E; Anderson SD; Romer LM; Bjermer L; Kippelen P
    J Appl Physiol (1985); 2013 Nov; 115(10):1450-6. PubMed ID: 24030662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute salbutamol inhalation on quadriceps force and fatigability.
    Decorte N; Verges S; Flore P; Guinot M; Wuyam B
    Med Sci Sports Exerc; 2008 Jul; 40(7):1220-7. PubMed ID: 18580400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.
    Fishwick D; Bradshaw L; Macdonald C; Beasley R; Gash D; Bengtsson T; Bondesson E; Borgström L
    Am J Respir Crit Care Med; 2001 Feb; 163(2):474-7. PubMed ID: 11179125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes.
    Heir T; Stemshaug H
    Scand J Med Sci Sports; 1995 Aug; 5(4):231-6. PubMed ID: 7552768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
    Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.